Thalidomide as an anti-TNF-α inhibitor

Implications for clinical use

Jeffrey D. Klausner, Victoria H. Freedman, Gilla Kaplan

Research output: Contribution to journalArticle

111 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)219-223
Number of pages5
JournalClinical Immunology and Immunopathology
Volume81
Issue number3
DOIs
StatePublished - Dec 1996
Externally publishedYes

Fingerprint

Thalidomide
Tumor Necrosis Factor-alpha

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pathology and Forensic Medicine

Cite this

Thalidomide as an anti-TNF-α inhibitor : Implications for clinical use. / Klausner, Jeffrey D.; Freedman, Victoria H.; Kaplan, Gilla.

In: Clinical Immunology and Immunopathology, Vol. 81, No. 3, 12.1996, p. 219-223.

Research output: Contribution to journalArticle

@article{a50f121d135348c389004f5416f2d185,
title = "Thalidomide as an anti-TNF-α inhibitor: Implications for clinical use",
author = "Klausner, {Jeffrey D.} and Freedman, {Victoria H.} and Gilla Kaplan",
year = "1996",
month = "12",
doi = "10.1006/clin.1996.0181",
language = "English (US)",
volume = "81",
pages = "219--223",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Thalidomide as an anti-TNF-α inhibitor

T2 - Implications for clinical use

AU - Klausner, Jeffrey D.

AU - Freedman, Victoria H.

AU - Kaplan, Gilla

PY - 1996/12

Y1 - 1996/12

UR - http://www.scopus.com/inward/record.url?scp=0030560905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030560905&partnerID=8YFLogxK

U2 - 10.1006/clin.1996.0181

DO - 10.1006/clin.1996.0181

M3 - Article

VL - 81

SP - 219

EP - 223

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 3

ER -